Description: Hypera S.A. operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, MaxSulid, milgamma, Mioflex " A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands. The company also provides dermo-cosmetics products under the Mantecorp Skincare brands; and consumer health products under the Apracur, Benegrip, Coristina d, Engov, Epocler, Estomazil, and other brands. In addition, it offers nutritional and vitamin supplement products under the Tamarine, Vitasay, Biotônico Fontoura, and Zero-Cal brands; and similar and generic medicines under the Neo Química, Sodium Diclofenac, Hydroxyzine, Dipyron, Ibuprofen, Losartan Potassium, Mal Dexchlorpheniramine, Naproxene, Paracetamol, Simethicon, Loratadine, Omeprazole, Tadalaphyl, and Desogestrel brand names. The company was formerly known as Hypermarcas S.A. and changed its name to Hypera S.A. in February 2018. Hypera S.A. is based in São Paulo, Brazil.
Home Page: www.hyperapharma.com.br
Av. Magalhães de Castro, 4800
São Paulo,
SP
05676-120
Brazil
Phone:
55 11 3627 4206
Officers
Name | Title |
---|---|
Mr. Breno Toledo Pires de Oliveira | CEO & Director |
Mr. Adalmario Ghovatto Satheler do Couto | Investor Relations Officer & CFO |
Mr. Carlos Roberto Scorsi | Chief Operating officer |
Juliana Aguinaga Damião Salem | Sr. Legal Officer |
Joao Felipe Khamis Aguilar | Risks & Compliance Officer |
Mr. Luiz Eduardo Sales Clavis | VP of Sales & Marketing |
Mauricio Christovam | Sr. HR Officer |
Mr. Nelson José de Mello | Chief Corp. Relations Officer |
Mr. Hélio Segouras | Head of Consumer Health |
Mr. Martim Prado Mattos | Sec. |
Exchange: SA
Country: BR
Currency: Brazilian real (R$)
GIC Sector: | Health Care |
---|---|
GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
GIC Industry: | Pharmaceuticals |
GIC Sub-Industry: | Pharmaceuticals |
Forward PE: | 14.1643 |
---|---|
Trailing PE: | 17.3463 |
Price-to-Book MRQ: | 2.5547 |
Price-to-Sales TTM: | 3.7905 |
IPO Date: | |
Fiscal Year End: | December |
Full Time Employees: | 9000 |